Sale!

IgVH Hypermutation Analysis Confirmatory Test

Original price was: 5,200 د.إ.Current price is: 4,680 د.إ.

-10%

The IgVH Hypermutation Analysis Confirmatory Test is a sophisticated diagnostic procedure designed to analyze the immunoglobulin heavy chain variable region (IgVH) for somatic hypermutation. This test is crucial in the clinical setting for patients with chronic lymphocytic leukemia (CLL) and other B-cell disorders, as the presence or absence of somatic hypermutations in the IgVH gene has significant prognostic implications. Patients with unmutated IgVH genes tend to have a more aggressive disease course and poorer prognosis, making this test essential for guiding treatment decisions and predicting patient outcomes.

Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, this test utilizes cutting-edge technology to ensure accurate and reliable results. The cost of the IgVH Hypermutation Analysis Confirmatory Test is 4680 AED. This investment in diagnostic precision enables healthcare providers to tailor treatment strategies more effectively, offering a personalized approach to patient care in the context of B-cell malignancies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IgVH Hypermuation Analysis Confirmatory Test

Are you looking for a reliable genetic lab in UAE? DNA Labs UAE offers the IgVH hypermutation analysis confirmatory test at an affordable price of 4680.0 AED.

Test Details

The IgVH hypermutation analysis confirmatory test is a diagnostic test used to confirm the presence of hypermutation in the immunoglobulin variable region genes (IgVH) of B cells. Hypermutation refers to a process where the genetic sequence of the IgVH genes undergoes frequent mutations, leading to increased diversity of antibodies produced by B cells.

This test is typically performed in patients suspected of having certain B cell disorders, such as chronic lymphocytic leukemia (CLL) or other lymphoproliferative disorders. The presence of hypermutation in the IgVH genes can provide important information about the disease progression and prognosis.

Test Components

  • Price: 4680.0 AED
  • Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
  • Report Delivery: Sample Mon by 11 am; Report 10 days
  • Method: Next Generation Sequencing
  • Test Type: Leukemia
  • Doctor: Hematologist, Oncologist
  • Test Department: MOLECULAR DIAGNOSTICS
  • Pre Test Information: No special preparation required

How the Test Works

The test involves sequencing the IgVH genes from a patient’s B cells and comparing them to a reference sequence. If the patient’s IgVH genes show a high number of mutations compared to the reference sequence, it confirms the presence of hypermutation.

Importance of the Test

The IgVH hypermutation analysis confirmatory test is a valuable tool in diagnosing and monitoring B cell disorders. It helps healthcare professionals understand the underlying genetic changes in B cells, which can guide treatment decisions and predict disease outcomes.

Don’t wait any longer. Contact DNA Labs UAE today to schedule your IgVH hypermutation analysis confirmatory test and get the answers you need.

Test Name IgVH HYPERMUTATION ANALYSIS CONFIRMATORY Test
Components
Price 4680.0 AED
Sample Condition 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
Report Delivery Sample Mon by 11 am; Report 10 days
Method Next Generation Sequencing
Test type Leukemia
Doctor Hematologist, Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information No special preparation required
Test Details

The IgVH hypermutation analysis confirmatory test is a diagnostic test used to confirm the presence of hypermutation in the immunoglobulin variable region genes (IgVH) of B cells. Hypermutation refers to a process where the genetic sequence of the IgVH genes undergoes frequent mutations, leading to increased diversity of antibodies produced by B cells.

This test is typically performed in patients suspected of having certain B cell disorders, such as chronic lymphocytic leukemia (CLL) or other lymphoproliferative disorders. The presence of hypermutation in the IgVH genes can provide important information about the disease progression and prognosis.

The test involves sequencing the IgVH genes from a patient’s B cells and comparing them to a reference sequence. If the patient’s IgVH genes show a high number of mutations compared to the reference sequence, it confirms the presence of hypermutation.

The IgVH hypermutation analysis confirmatory test is a valuable tool in diagnosing and monitoring B cell disorders. It helps healthcare professionals understand the underlying genetic changes in B cells, which can guide treatment decisions and predict disease outcomes.